A third vaccination with a single T cell epitope confers protection in a murine model of SARS-CoV-2 infection

Nat Commun. 2022 Jul 8;13(1):3966. doi: 10.1038/s41467-022-31721-6.

Abstract

Understanding the mechanisms and impact of booster vaccinations are essential in the design and delivery of vaccination programs. Here we show that a three dose regimen of a synthetic peptide vaccine elicits an accruing CD8+ T cell response against one SARS-CoV-2 Spike epitope. We see protection against lethal SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model in the absence of neutralizing antibodies, but two dose approaches are insufficient to confer protection. The third vaccine dose of the single T cell epitope peptide results in superior generation of effector-memory T cells and tissue-resident memory T cells, and these tertiary vaccine-specific CD8+ T cells are characterized by enhanced polyfunctional cytokine production. Moreover, fate mapping shows that a substantial fraction of the tertiary CD8+ effector-memory T cells develop from re-migrated tissue-resident memory T cells. Thus, repeated booster vaccinations quantitatively and qualitatively improve the CD8+ T cell response leading to protection against otherwise lethal SARS-CoV-2 infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Neutralizing
  • Antibodies, Viral
  • CD8-Positive T-Lymphocytes
  • COVID-19* / prevention & control
  • Disease Models, Animal
  • Epitopes, T-Lymphocyte*
  • Immunologic Memory
  • Mice
  • SARS-CoV-2
  • Spike Glycoprotein, Coronavirus
  • Vaccination
  • Vaccines, Synthetic

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Epitopes, T-Lymphocyte
  • Spike Glycoprotein, Coronavirus
  • Vaccines, Synthetic
  • spike protein, SARS-CoV-2